| Bioactivity | Anticancer agent 230 (example 65) is a caseinolytic protease P (ClpP) activator with anticancer activity. Anticancer agent 230 is able to induce the degradation of mitochondrial proteins in SUM159 and MDA-MB-231 triple-negative breast cancer cells in a time-dependent manner[1]. |
| CAS | 2485052-87-5 |
| Formula | C22H19ClN4O |
| Molar Mass | 390.87 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Preparation of tetrahydropyrido[4,3-d]pyrimidine-2,4-dione analogs useful in the treatment of cancers and in modulating the activity of caseinolytic protease p function. United States, US20230339947 A1. 2023-10-26. |
Anticancer agent 230
CAS: 2485052-87-5 F: C22H19ClN4O W: 390.87
Anticancer agent 230 (example 65) is a caseinolytic protease P (ClpP) activator with anticancer activity. Anticancer age
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.